WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 11, Pages 1743
Publisher
MDPI AG
Online
2019-11-08
DOI
10.3390/cancers11111743
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intracellular BH3 Profiling Reveals Shifts in Antiapoptotic Dependency in Human B Cell Maturation and Mitogen-Stimulated Proliferation
- (2018) Joanne Dai et al. JOURNAL OF IMMUNOLOGY
- Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach
- (2018) Mathilde R. W. de Jong et al. PLoS One
- Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
- (2018) Andrea Ghelli Luserna Di Rorà et al. Journal of Hematology & Oncology
- BCL-W has a fundamental role in B cell survival and lymphomagenesis
- (2017) Clare M. Adams et al. JOURNAL OF CLINICAL INVESTIGATION
- WEE1 inhibition by MK1775 as a single-agent therapy inhibits ovarian cancer viability
- (2017) Minghui Zhang et al. Oncology Letters
- Dynamics of the mitochondrial network during mitosis
- (2016) Gil Kanfer et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MCL-1 Depletion Impairs DNA Double-Strand Break Repair and Reinitiation of Stalled DNA Replication Forks
- (2016) Abid R. Mattoo et al. MOLECULAR AND CELLULAR BIOLOGY
- Drug-Induced Death Signaling Strategy Rapidly Predicts Cancer Response to Chemotherapy
- (2015) Joan Montero et al. CELL
- Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma
- (2015) M. Klanova et al. CLINICAL CANCER RESEARCH
- Extensive RPA2 hyperphosphorylation promotes apoptosis in response to DNA replication stress in CHK1 inhibited cells
- (2015) Pedro Zuazua-Villar et al. NUCLEIC ACIDS RESEARCH
- AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair
- (2015) James B. Ford et al. Oncotarget
- Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
- (2015) Enrico Derenzini et al. Oncotarget
- A regimen combining the Wee1 inhibitor AZD1775 with HDAC inhibitors targets human acute myeloid leukemia cells harboring various genetic mutations
- (2014) L Zhou et al. LEUKEMIA
- BH3 profiling in whole cells by fluorimeter or FACS
- (2013) Jeremy Ryan et al. METHODS
- Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
- (2013) A. D. Guertin et al. MOLECULAR CANCER THERAPEUTICS
- BaxΔ2 Is a Novel Bax Isoform Unique to Microsatellite Unstable Tumors
- (2012) Bonnie Haferkamp et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mitochondrial hyperfusion induced by loss of the fission protein Drp1 causes ATM-dependent G2/M arrest and aneuploidy through DNA replication stress
- (2012) W. Qian et al. JOURNAL OF CELL SCIENCE
- Cyclin-Dependent Kinase Suppression by WEE1 Kinase Protects the Genome through Control of Replication Initiation and Nucleotide Consumption
- (2012) H. Beck et al. MOLECULAR AND CELLULAR BIOLOGY
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- Chromosomal Instability Substantiates Poor Prognosis in Patients with Diffuse Large B-cell Lymphoma
- (2011) S. F. Bakhoum et al. CLINICAL CANCER RESEARCH
- BCL2 Predicts Survival in Germinal Center B-cell-like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
- (2011) J. Iqbal et al. CLINICAL CANCER RESEARCH
- BCL2 mutations in diffuse large B-cell lymphoma
- (2011) J M Schuetz et al. LEUKEMIA
- Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
- (2010) Halfdan Beck et al. JOURNAL OF CELL BIOLOGY
- Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
- (2010) Wyndham H Wilson et al. LANCET ONCOLOGY
- Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis
- (2009) D. T. Terrano et al. MOLECULAR AND CELLULAR BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search